Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.4.23.17 (PCE)
 1,301 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Various nucleoside analogues are being used or are being considered for use as therapeutic drugs to inhibit replication of the HTLV-III/LAV virus in infected human cells. Here, the ability of seven nucleoside analogues, a combination of two analogues, and two other therapeutic compounds to induce genotoxic and cytotoxic damage in vivo was evaluated in the mouse bone marrow micronucleus test. Using a 3-consecutive-day oral treatment protocol, almost all of the test chemicals induced a significant increase in the frequency of micronucleated polychromatic erythrocytes (MN-PCE) in male B6C3F1 mice, ranked in decreasing potency as 6-thioguanine greater than Cytarabine HCl greater than 3'-azido-3'-deoxythymidine (AZT)/2',3'-dideoxycytidine combination = AZT greater than Ribavirin = 2',3'-didehydro-3'-deoxythymidine greater than 2',3'-dideoxyadenosine = 2',3'-dideoxycytidine. The frequency of MN-PCE was not increased significantly by treatment with 2',3-dideoxyinosine (DDI) or pentamidine isethionate (PI). The differential ability of AZT and DDI to induce MN in mouse bone marrow was verified from peripheral blood smears prepared from subchronic (90 day) oral studies. The lack of genotoxic activity by DDI was route-specific since, when tested by intraperitoneal injection, a small but significant increase in MN-PCE was observed. A number of these chemicals induced a significant depression in erythropoiesis. However, there was not a significant correlation between the increase in MN-PCE and the depression in the percentage of PCE. This lack of a correlation suggests that factors other than DNA damage may contribute to the inhibition in the rate of erythropoiesis. The presence of increased levels of micronuclei in bone marrow PCE following treatment with various nucleoside analogues suggests that intrinsic genotoxic activity in mammalian cells should be one factor considered during drug selection for AIDS therapy.
 ...
PMID:Induction of micronuclei in mouse bone marrow cells: an evaluation of nucleoside analogues used in the treatment of AIDS. 191 12

Flux in non-aqueous-phase liquid (NAPL)-contaminated systems containing active microbial populations (including Dehalococcoides sp.) was investigated using a quantitative mass balance and phase distribution approach. Batch systems containing mixed NAPL with an initial tetrachloroethene (PCE) mole fraction ranging from 0.1 to 0.4 provided a means for comparing systems where mass transfer and aqueous concentration were controlled by the initial NAPL composition. Although the use of mixed NAPL with increasing PCE mole fractions introduced a mass-transfer variable on the abiotic dissolution rate, it was determined that biological systems produced flux rates that were similar to each other regardless of the initial PCE mole fraction. Thus, organisms appeared to be dechlorinating near their maximum conversion rates, and the result was the accumulation of cis-1,2-dichloroethene (cDCE) followed by slow conversion to vinyl chloride (VC). Increases in the initial PCE mole fractions in the NAPL had a negative impact on product distribution due to the presence of a larger concentration of a more favorable electron acceptor. Because the mass converted to cDCE was present largely in the dissolved phase in all systems, the production of this metabolite was a favorable outcome in terms of NAPL dissolution. The pH dropped as low as 4.9 in active systems, indicating that the amount of HCl released during the reductive dechlorination process was large enough to overwhelm the buffering capacity. This pH effect was more pronounced in systems that exhibited extensive dechlorination to VC, further suggesting that rapid dechlorination of PCE NAPL can alter chemical characteristics in source zone regions.
 ...
PMID:Flux and product distribution during biological treatment of tetrachloroethene dense non-aqueous-phase liquid. 1511 2

The effect of edible oil emulsion treatment on enhanced reductive dechlorination was evaluated in a 14 month laboratory column study. Experimental treatments included: (1) emulsified soybean oil and dilute HCl to inhibit biological activity; (2) emulsified oil only; (3) emulsified oil and anaerobic digester sludge; and (4) continuously feeding soluble substrate. A single application of emulsified oil was effective in generating strongly reducing, anaerobic conditions for over 14 months. PCE was rapidly reduced to cis-DCE in all three live columns. Bioaugmentation with a halorespiring enrichment culture resulted in complete dechlorination of PCE to ethene in the soluble substrate column (yeast extract and lactate). However, an additional treatment with a pulse of yeast extract and bioaugmentation culture was required to stimulate complete dechlorination in the emulsion treated columns. Once the dechlorinating population was established, the emulsion only column degraded PCE from 90-120 microM to below detection with concurrent ethene production in a 33 day contact time. The lower biodegradation rates in the emulsion treated columns compared to the soluble substrate column suggest that emulsified oil barriers may require a somewhat longer contact time for effective treatment. In the HCl inhibited column, partitioning of PCE to the retained oil substantially delayed PCE breakthrough. However, reduction of PCE to more soluble degradation products (cis-DCE, VC and ethene) greatly reduced the impact of oil-water partitioning in live columns. There was only a small decline in the hydraulic conductivity (K) of column #1 (low pH+emulsion, K(final)/K(initial)=0.57) and column #2 (live+emulsion, K(final)/K(initial)=0.73) indicating emulsion injection did not result in appreciable clogging of the clayey sand. However, K loss was greater in column #3 (sludge+emulsion, K(final)/K(initial)=0.12) and column #4 (soluble substrate, K(final)/K(initial)=0.03) indicating clogging due to biomass and/or gas production can be significant.
 ...
PMID:Enhanced reductive dechlorination in columns treated with edible oil emulsion. 1679 70

In situ treatment of dense nonaqueous phase liquids (DNAPL) by enhanced reductive dechlorination (ERD) can be limited by contaminant toxicity, low pH, and challenges in effectively delivering electron donor. Flushing emulsified vegetable oil (EVO), colloidal Mg(OH)2 buffer, and a bioaugmentation culture (BC) through a zone containing neat tetrachloroethene (PCE) was effective in reducing contaminant toxicity, limiting pH declines, and accelerating bioenhanced dissolution of the DNAPL. In the effluent of porous media columns with little fine material, PCE concentrations reached a maximum of 40-50 times PCE aqueous solubility in water, demonstrating NAPL PCE was distributed throughout the 1.5 m column length. In a column treated with only EVO+BC, reductive dechlorination was limited. However, a single injection of EVO+Mg(OH)2+BC was effective in reducing PCE to below detection for over 400 days with a large increase in Cl(-) and dichloroethene (DCE), accelerating bioenhanced DNAPL dissolution. Dechlorination rates gradually increased over time with the rate of total ethene (TE) release from the Mg(OH)2+EVO+BC column reaching 5-6 times the TE release rate from the EVO+BC column. The accelerated dechlorination was likely due to both Mg(OH)2 addition which limited pH declines from HCl, volatile fatty acids (VFAs), and inorganic carbon (IC) production, and formation of a mixed PCE-vegetable oil NAPL which provided a readily accessible electron donor, resulting in rapid PCE degradation with reduced PCE toxicity.
...
PMID:Enhanced reductive dechlorination of tetrachloroethene dense nonaqueous phase liquid with EVO and Mg(OH)2. 2432 64